Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2026)

Hims & Hers Health (HIMS) reported Capital Expenditures of $29.8 million for Q1 2026, down 46.06% on a YoY basis from $55.3 million in Q1 2025, and up 357.34% sequentially from -$11.6 million in Q4 2025.

Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of Capital Expenditures data on file, last reported at $29.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures fell 46.06% year-over-year to $29.8 million; the trailing twelve-month figure through Mar 2026 stood at -$239000.0 (down 100.43% YoY), and the FY2025 full-year result was $25.2 million, up 44978.57% from the prior year.
  • Capital Expenditures improved to $29.8 million in Q1 2026, from -$11.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $55.3 million in Q1 2025 to a low of -$47.4 million in Q2 2025.
  • A 5-year average of $4.8 million and a median of $1.3 million in 2023 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures plunged 262.43% in 2024 and jumped 117617.02% in 2025, its largest moves.
  • Tracing HIMS's Capital Expenditures over 5 years: stood at -$17000.0 in 2022, then jumped by 61952.94% to $10.5 million in 2023, then sank by 262.43% to -$17.1 million in 2024, then jumped by 32.1% to -$11.6 million in 2025, then surged by 357.34% to $29.8 million in 2026.
  • Business Quant data shows HIMS's Capital Expenditures at $29.8 million in Q1 2026, -$11.6 million in Q4 2025, and $28.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 99.60 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 51.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 29.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.84 Mn
Mar 31, 2026 29.84 Mn
Dec 31, 2025 -11.60 Mn
Dec 31, 2025 -11.60 Mn
Sep 30, 2025 28.88 Mn
Sep 30, 2025 28.88 Mn
Jun 30, 2025 -47.37 Mn
Jun 30, 2025 -47.37 Mn
Mar 31, 2025 55.33 Mn
Mar 31, 2025 55.33 Mn
Dec 31, 2024 -17.08 Mn
Dec 31, 2024 -17.08 Mn
Sep 30, 2024 17.09 Mn
Sep 30, 2024 17.09 Mn
Mar 31, 2024 47,000.00
Mar 31, 2024 47,000.00
Dec 31, 2023 10.52 Mn
Dec 31, 2023 10.52 Mn
Sep 30, 2023 1.39 Mn
Sep 30, 2023 1.39 Mn